SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Triangle Pharmaceuticals (VIRS) -- Ignore unavailable to you. Want to Upgrade?

To: Jack Hartmann who wrote (31)3/31/2000 4:16:00 PM
From: wbASSETt  Respond to of 34
 
VIRS closed up 25% today. That ought to breath some life into this one!
wb



To: Jack Hartmann who wrote (31)11/4/2003 5:20:32 PM
From: Jack Hartmann  Respond to of 34
 
In January 2003, Triangle Pharmaceuticals was acquired by Gilead Sciences, Inc. (U. S.) in a transaction valued at $464 million


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News